In Vitro Evaluation of Two Novel Antimalarial Derivatives of SKM13: SKM13-MeO and SKM13-F

• Published in: Korean journal of parasitology Vol. 60; no. 6; pp. 401 - 407
• Main Authors: Trinh, Thuy-Tien Thi, Kim, Young-Ah, Hong, Hyelee, Le, Linh Thi Thuy, Jang, Hayoung, Kim, Soon-Ai, Park, Hyun, Kim, Hak Sung, Yeo, Seon-Ju
• Format: Journal Article
• Language: English
• Published: Korea (South) 대한기생충학열대의학회 01-12-2022; The Korean Society for Parasitology and Tropical Medicine
• Subjects: Animals; Antimalarials - pharmacology; Antimalarials - therapeutic use; Malaria; Malaria, Falciparum - drug therapy; Original; Plasmodium falciparum; Trophozoites; chloroquine derivative; SKM13; malaria; antimalarial drug; Plasmodium spp
• ISSN: 0023-4001; 1738-0006
• DOI: 10.3347/kjp.2022.60.6.401

Antimalarial drugs play an important role in the control and treatment of malaria, a deadly disease caused by the protozoan parasite Plasmodium spp. The development of novel antimalarial agents effective against drug-resistant malarial parasites is urgently needed. The novel derivatives, SKM13-MeO and SKM13-F, were designed based on an SKM13 template by replacing the phenyl group with electron-donating (-OMe) or electron-withdrawing groups (-F), respectively, to reverse the electron density. A colorimetric assay was used to quantify cytotoxicity, and in vitro inhibition assays were performed on 3 different blood stages (ring, trophozoite, and schizonts) of P. falciparum 3D7 and the ring/mixed stage of D6 strain after synchronization. The in vitro cytotoxicity analysis showed that 2 new SKM13 derivatives reduced the cytotoxicity of the SKM13 template. SKM13 maintained the IC50 at the ring and trophozoite stages but not at the schizont stage. The IC50 values for both the trophozoite stage of P. falciparum 3D7 and ring/mixed stages of D6 demonstrated that 2 SKM13 derivatives had decreased antimalarial efficacy, particularly for the SKM13-F derivative. SKM13 may be comparably effective in ring and trophozoite, and electron-donating groups (-OMe) may be better maintain the antimalarial activity than electron-withdrawing groups (-F) in SKM13 modification.